Scendea
↗Hertfordshire, United Kingdom
Scendea is an international product development and regulatory consulting firm serving the pharmaceutical and biotechnology industries. The company provides strategic and operational support across non-clinical, CMC, clinical, and regulatory domains to guide medicinal products from early development through to marketing approval.
In addition to its core consulting services, Scendea operates a dedicated compliance division that offers CRO/CDMO oversight, GxP audits, and quality management system (QMS) support. Founded as a management buyout of a clinical research organization's consulting function, the company leverages over 20 years of experience to help clients reduce time-to-market and minimize development costs.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2013
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Modalities:General Pharma/Biotech
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:Indegene, IntegriChain, ProPharma Group, Prescient Healthcare Group
LEADERSHIP
Key Executives:
Paul Cronin - Director
Charles Camp - Managing Director UK & EU / CFO
Susan Jones - Managing Director Aus & Global Head of Quality
LINKS
Website:scendea.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Scendea and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Scendea. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.